Lv1
38 积分 2023-08-21 加入
Clinical relevance of extracellular vesicles in cancer — therapeutic and diagnostic potential
2小时前
待确认
Discovery and characterization of novel FGFR1 inhibitors in triple-negative breast cancer via hybrid virtual screening and molecular dynamics simulations
20天前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
27天前
已完结
Serial ctDNA to understand PARPi resistance
2个月前
已完结
Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer
2个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2个月前
已完结
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER+/HER2- breast cancer
3个月前
已完结
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial
3个月前
已完结
PPP2R1A mutations portend improved survival after cancer immunotherapy
4个月前
已完结
Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
5个月前
已完结
皖公网安备34019202002308
